Results 71 to 80 of about 280,867 (260)

Report on the 9th International Conference on Austroasiatic Linguistics (ICAAL9) at Lund University, Sweden, November 18–19, 2021

open access: yesJournal of the Southeast Asian Linguistics Society, 2022
This is a report on the 9th International Conference on Austroasiatic Linguistics (ICAAL9) at Lund University, Sweden,
Tobias Weber
doaj  

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

Conference Report: Worldcon 77 Academic Track

open access: yesFafnir, 2020
The 77th Worldcon, held August 15 to 19 in Dublin, included an academic track that ran from morning until late afternoon throughout the event. With an average of three papers per session and five sessions per day, the track offered a variety of topics ...
Jani Ylönen
doaj  

Report from the 5th International Asian Congress and the XII International Conference “The direction of Asia, diversity, dialogue on the 100th anniversary of Poland’s independence and Azerbaijan independence”, Toruń, Poland, 9–11 May 2018 [PDF]

open access: yesNowa Polityka Wschodnia, 2018
Report from the 5th International Asian Congress and the XII International Conference “The direction of Asia, diversity, dialogue on the 100th anniversary of Poland’s independence and Azerbaijan independence”, Toruń, Poland, 9–11 May ...
Kamila Rezmer
doaj  

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

IZVJEŠTAJ/CONFERENCE REPORT Izvještaj sa tribine „REFERENDUM ZA NEZAVISNOST REPUBLIKE BOSNE I HERCEGOVINE – 26 godina poslije“, Tuzla, 28. februar 2018. godine [PDF]

open access: yesHistorijski pogledi, 2018
IZVJEŠTAJ/CONFERENCE REPORT Izvještaj sa tribine „REFERENDUM ZA NEZAVISNOST REPUBLIKE BOSNE I HERCEGOVINE – 26 godina poslije“, Tuzla, 28.
Amir Krpić
doaj  

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

REPORTS OF SPECIAL CONFERENCES [PDF]

open access: yesAJN, American Journal of Nursing, 1912
n ...
openaire   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy